SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000902664-22-001112
Filing Date
2022-02-04
Accepted
2022-02-04 08:30:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 ADMA BIOLOGICS, INC. p22-0735sc13d.htm SC 13D 70252
  Complete submission text file 0000902664-22-001112.txt   71854
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82025 | Film No.: 22591100
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 590 MADISON AVENUE NEW YORK NY 10022
Business Address 590 MADISON AVENUE NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D